Returning for its 26th Annual Edition, this established global bio-pharma industry event will address the key challenges and investment trends for 2026, with a strong focus on partnering, alliance management, and future prospects. Leading industry figures will contribute their insights through a series of panel discussions covering the broader market outlook, as well as innovation across different therapeutic sectors.

The main programme for the 26th Annual BEF is spread throughout 2 days (7th - 8th of October) and will feature more than 15 hours of high-level keynotes and panel discussions. In addition, there will be a global company showcase of 50+ presentations by established public, private, emerging, and seed companies, offering innovative solutions and seeking investment and partnering opportunities. This will include a limited number of live presentations taking place in dedicated parallel presentation tracks, including the plenary Rising Stars – Biotech Seed Companies Session, covering biotech, drug discovery, and diagnostic start-ups from across Europe. In addition, there will be virtual company showcases available on demand during the virtual week.

We anticipate 650+ delegates will register for the forum from across the life sciences sector, bringing together a global audience of senior pharma, biotech, and HealthTech executives, bankers, consultants, and financial and corporate investors, alongside a select number of service providers, with part of the audience also participating virtually. Supported and designed by leading figures within Europe’s pharmaceutical and biotech industry, this event will once again be covered by our regular media partners.

Members of the Swiss Biotech Association benefit from a 15% discount on registration or showcase packages with Online Meeting System Access.